Regulating drugs for effectiveness and safety: a pu... [Med Care. 2007] - PubMed

Supplemental Content

Related citations

Prescription drugs, alternative designs, and the Restatement (Third): preliminary reflections. [Seton Hall Law Rev. 1999]
Prescription drugs, alternative designs, and the Restatement (Third): preliminary reflections.
Green MD. Seton Hall Law Rev. 1999; 30(1):207-32.
The HEALTH Act's FDA defense to punitive damages: a gift to drug makers or to the public? [Fordham Law Rev. 2006]
The HEALTH Act's FDA defense to punitive damages: a gift to drug makers or to the public?
Levy E. Fordham Law Rev. 2006 Mar; 74(4):2425-60.
Promoting public health and protecting consumers in a global economy: an overview of HHS/FDA's international activities. [Food Drug Law J. 2005]
Promoting public health and protecting consumers in a global economy: an overview of HHS/FDA's international activities.
Kelly DP, Bachorik LL. Food Drug Law J. 2005; 60(3):339-46.
Review The US Food and Drug Administration Modernization Act of 1997: impact on consumers. [Clin Ther. 1998]
Review The US Food and Drug Administration Modernization Act of 1997: impact on consumers.
Golodner LF. Clin Ther. 1998; 20 Suppl C:C20-5.
Review Development of safety qualification thresholds and their use in orally inhaled and nasal drug product evaluation. [Toxicol Sci. 2007]
Review Development of safety qualification thresholds and their use in orally inhaled and nasal drug product evaluation.
Ball D, Blanchard J, Jacobson-Kram D, McClellan RO, McGovern T, Norwood DL, Vogel W, Wolff R, Nagao L. Toxicol Sci. 2007 Jun; 97(2):226-36. Epub 2007 Mar 16.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Regulating drugs for effectiveness and safety: a public health perspective.
Regulating drugs for effectiveness and safety: a public health perspective.
Med Care. 2007 Sep ;45(9):911.

PubMed
O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clin...
O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines.
Clin Cancer Res. 2005 Apr 1 ;11(7):2747-55.

PubMed
Apoptosis: the importance of nuclear medicine.
Apoptosis: the importance of nuclear medicine.
Nucl Med Commun. 2000 Mar ;21(3):241-50.

PubMed
Provider treatment intensity and outcomes for patients with early-stage bladder ...
Provider treatment intensity and outcomes for patients with early-stage bladder cancer.
J Natl Cancer Inst. 2009 Apr 15 ;101(8):571-80. Epub 2009 Apr 7 .

PubMed
Seasonal variation of transient acantholytic dyskeratosis (Grover's disease).
Seasonal variation of transient acantholytic dyskeratosis (Grover's disease).
J Am Acad Dermatol. 2006 Aug ;55(2):263-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Regulating drugs for effectiveness and safety: a public health perspective.

Source

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Related citations

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information